Perceptive Advisors’s MGC Diagnostics Corporation MGCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-252,327
Closed -$2.26M 172
2017
Q3
$2.26M Hold
252,327
0.09% 90
2017
Q2
$2.14M Sell
252,327
-50,000
-17% -$411K 0.11% 81
2017
Q1
$2.52M Sell
302,327
-27,406
-8% -$242K 0.14% 78
2016
Q4
$2.6M Hold
329,733
0.19% 75
2016
Q3
$2.27M Sell
329,733
-6,554
-2% -$45.3K 0.15% 83
2016
Q2
$2.19M Hold
336,287
0.15% 83
2016
Q1
$2.04M Hold
336,287
0.18% 87
2015
Q4
$2.21M Hold
336,287
0.16% 71
2015
Q3
$2.22M Hold
336,287
0.18% 75
2015
Q2
$1.76M Hold
336,287
0.11% 104
2015
Q1
$2.48M Hold
336,287
0.19% 79
2014
Q4
$2.15M Buy
336,287
+8,799
+3% +$57.4K 0.18% 86
2014
Q3
$2.23M Buy
327,488
+11,029
+3% +$85.4K 0.23% 69
2014
Q2
$2.65M Buy
316,459
+109,502
+53% +$1.08M 0.26% 58
2014
Q1
$2.31M Buy
206,957
+27,338
+15% +$309K 0.24% 62
2013
Q4
$2.27M Buy
179,619
+5,170
+3% +$63.2K 0.27% 46
2013
Q3
$1.91M Hold
174,449
0.16% 62
2013
Q2
$1.46M Buy
+174,449
New +$1.27M 0.15% 54

Other funds holding MGCD

Perceptive Advisors's MGCD Position: Q4 2017 in Review

Perceptive Advisors sold out of MGC Diagnostics Corporation (MGCD) in Q4 2017, closing a stake of 252,327 shares — an estimated $2.26M sold.

Perceptive Advisors first reported a position in MGCD in Q2 2013 and held it in 18 quarters. The position peaked at $2.65M in Q2 2014. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.

  • Perceptive Advisors reported no remaining MGC Diagnostics Corporation position as of Q4 2017 after selling out during the quarter.
  • Perceptive Advisors sold 252,327 MGC Diagnostics Corporation shares in Q4 2017, an estimated $2.26M.
  • Perceptive Advisors first reported a position in MGC Diagnostics Corporation in Q2 2013 and held it in 18 quarters.
  • Perceptive Advisors's MGC Diagnostics Corporation position peaked at $2.65M in Q2 2014.
  • 12 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2017.

Based on Perceptive Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.